Drug Type TCR-T Cell therapy |
Synonyms HRYZ T102, HRYZ-T102, HRYZT102 |
Target |
Action inhibitors |
Mechanism AFP inhibitors(Alpha-fetoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Hepatocellular Carcinoma | Phase 1 | China | 10 Aug 2024 | |
Hepatocellular Carcinoma | Phase 1 | China | 10 Aug 2024 |